BIRC2 and cancer: We chose to validate BIRC2 by qPCR because it is an upregulated member of the NOD2 pathway at a crossroads between growth, immunity, and cancer, yet BIRC2 has been reported to have no phenotype when knocked down in C. elegans [45].